About this item
About this item
Important Made in USA Origin Disclaimer: For certain items sold by Walmart on Walmart.com, the displayed country of origin information may not be accurate or consistent with manufacturer information. For updated, accurate country of origin data, it is recommended that you rely on product packaging or manufacturer information.
Hardcover, Woodhead Publishing, 2012, ISBN13 9781907568602, ISBN10 1907568603
Summary: - in-depth discussion of case studies of products undergoing development - focus on commercial optimization of stem cell treatments - analysis in a global context and covering a diverse range of countries - comparison between different national strategies, policies and best practices - discussion of non-human applications of stem cell therapies, a revolutionary growth area Promising new developments in biomedical technology such as stem cell science are widely endorsed by governments keen to reduce spiralling healthcare costs, clinicians focused on patient care and patients demanding revolutionary new treatments. Commercializing the stem cell sciences offers a comparative analysis of the commercial methods adopted in the global stem cell industries, and seeks to establish whether there is an optimum commercial model, and to examine what emerging companies can learn from their predecessors. Following an introduction to stem cell sciences and the problems involved in their commercialization, the book begins with a discussion of stem cell treatments from a global perspective, and the role of innovation in the commercialization of biotechnology in general. In the second half of the book, chapters focus on the different strategies that can be employed and their relative risks and values, before a conclusion that looks at potential new developments in the field. About the author: Olivia Harvey is currently a Visiting Fellow with the Biopolitics of Science Research Network at the University of Sydney. She was previously a Faculty of Arts and Social Sciences Postdoctoral Research Fellow and Research Fellow in the School of History and Philosophy at the Universty of New South Wales and an Economic and Social Research Council Postdoctoral Research Fellow and Research Fellow with the Global Biopolitics Research Group (formerly of the University of East Anglia), Centre for Biomedicine and Society (now at Brunel University), King's College, London. Contents: Introduction: Stem cell science, biotechnology and the problem of commercialization; Stem cell treatments in a global marketplace; The role of innovation systems in the commercialization of biotechnology; Low-risk, low value strategies: Adult stem cells; High-risk, high-value: embryonic stem cells; Low-risk, low-value: iPS cells; Conclusion: What will happen next?
|Number of Pages:||194|
|Number in Series:||1|
|Series Title:||Woodhead Publishing Series in Biomedicine|
|Publisher:||Woodhead Pub Ltd|
|Publication Date:||October, 2012|
|Assembled Product Dimensions (L x W x H):||6.50 x 10.00 x 0.75 Inches|
Ask a question
If you would like to share feedback with us about pricing, delivery or other customer service issues, please contact customer service directly.
Questions will be checked against our question guidelines and posted within five to seven business days.